Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Azd3470 – Application in Therapy and Current Clinical Research
AZD3470 for Blood Cancer Clinical Trial 2024 | Power
AZD3470 for Advanced Solid Cancers Clinical Trial 2024 | Power
阿斯利康入局二代PRMT5抑制剂，AZD3470登记I期临床 - 知乎
“合成致死”新靶点！阿斯利康新型PRMT5抑制剂AZD3470获批临床，针对晚期实体瘤
PRMT5抑制剂AZD3470片治疗MTAP缺失食管癌-印塔健康官网
阿斯利康二代PRMT5抑制剂在华申报临床 11月20日，CDE官网显示， 阿斯利康 的二代PRMT5抑制剂AZD3470薄膜衣片的临床试验申请 ...
阿斯利康二代PRMT5抑制剂AZD3470在华申报临床，针对实体瘤
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor ...
【AZD3470】進行性固形がん / 第I相試験 / MTA協同的PRMT5阻害薬 / 抗がん剤 | 国立がん研究センター中央病院 先端医療科 ...
阿斯利康 9 款 1 类新药在中国获批临床，多款国内进度位于第一梯队
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl ...
Abstract LB008: Integrative dynamic MultiOMICs analysis identifies cell ...
PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety ...
Myocardial Steatosis and Necrosis in Atria and Ventricles of Rats Given ...
Chemical structure of AZD3965. | Download Scientific Diagram
药渡Cyber解析一种用于治疗MTAP缺失型癌症的强效选择性MTA协同PRMT5抑制剂TNG462的发现 - 知乎
PRIMROSE: A Modular Phase I/IIa, Multi-centre, Dose Escalation, and ...
A study of AZD3470, a PRMT5 inhibitor, in patients with MTAP deficient ...
PRMT5 is essential for B cell development and germinal center dynamics ...
Specific Targeting of MTAP-Deleted Tumors with a Combination of 2 ...
PRIMROSE: A modular phase 1/2a study of AZD3470, an MTA-cooperative ...
UCSF Solid Tumor Trial → AZD3470, a PRMT5 Inhibitor, in Patients With ...
百亿美元市场！领路者阿斯利康两手抓：奥拉帕利再获新适应症，下一代产品多款布局
AZD3147 | mTORC1/2 Inhibitor | MedChemExpress
Optimization of AZD1775-based analogues (adopted from Matheson et al ...
Arvinas公布ER PROTAC药物ARV-471二期临床数据 11月23日，PROTAC明星企业 Arvinas 在SABCS前几周就 ...
MTAP deletion confers enhanced dependency on the arginine ...
Exploiting Synthetic Lethality of PRMT5 for Precision Treatment of MTAP ...
Frontiers | Application and research progress of synthetic lethality in ...
本周国内创新药获批、NDA和IND；全球III期临床汇总_腾讯新闻
Paper: PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety ...
Frontiers | Methylthioadenosine phosphorylase deficiency in tumors: A ...
PRMT5抑制剂AZD3470片治疗MTAP缺失食管癌_研究_受试者_肿瘤
设计研发领域的新力量—Precision3470-荣顺达官网——戴尔工作站总代
Targeting PRMT5: Current Inhibitors and Emerging Strategies for ...
Figure 3 from Reductions in Myeloid-Derived Suppressor Cells and Lung ...
PRMT5-IN-1 | Histone Methyltransferase | TargetMol
UM research reveals combination therapy enhances proteasome inhibitor ...
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
AZD4547 inhibits spontaneous lung metastasis of 4T1 tumor-bearing mice ...
In Vivo Anticancer Activity of AZD3965: A Systematic Review
Study on Immune Markers for Checkpoint Inhibitor Toxicity in Cancer ...
Spiro[1H-isoindole-1,3′-pyrrolidine]-2′,3(2H)-dione, 2-[(5-amino-6 ...
Study of Azenosertib (ZN-c3) for Women with Recurrent or Persistent ...
Brett Bookser on LinkedIn: My first Drug Hunter article is here https ...
“合成致死”新靶点！阿斯利康新型PRMT5抑制剂获批临床_新浪财经_新浪网
Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy ...
Figure 2 from Reductions in Myeloid-Derived Suppressor Cells and Lung ...
Tumor‐Targeted Inhibition of Monocarboxylate Transporter 1 Improves T ...
In vivo efficacy of AZD3965 in the 4T1 breast tumor xenograft. The ...
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression ...
Study on the Effects of Durvalumab and Tazemetostat for Adults with ...
Study on Bepranemab for Patients with Early Alzheimer’s Disease
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell ...
Antitumor Effects and Mechanisms of AZD4547 on FGFR2-Deregulated ...
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in ...
The azide functional group, which occurs in azidobenzene, contains ...
Figure 6 from The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In ...
혈액암 개발 속도 붙이는 AZ…일주일 새 3건 임상 1/2상 IND 승인
Integrative Genomics Identifies the Molecular Basis of Resistance to ...
#esmo24 | Byung-June Park
Frontiers | Evaluation of Combination Strategies for the A2AR Inhibitor ...
Drug Hunter - drug discovery, distilled
JCI - Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2 ...
Pharmaceutics | Free Full-Text | Effects of Lactate Transport ...
Study on Afatinib and Osimertinib for Patients with EGFR-Mutated, T790M ...
Study Comparing Isatuximab with Lenalidomide, Bortezomib, and ...
Study on Brigatinib and Durvalumab for Patients with Unresectable Stage ...
(PDF) Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2 ...
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In ...
| AZD4547 is pan-TRK inhibitor. (A) Results of cancer cell screening of ...
Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients ...
Study on Carfilzomib, Lenalidomide, and Dexamethasone for Patients ...
,%20Lymphoma,%20Hodgkins,%20Lymphoma:%0A%0AAZD3470%20for%20Blood%20Cancer.png?md=1)
